Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Valion Bio, Inc. (VBIO)

Biodexa Pharmaceuticals PLC Unsponsored ADR and Valion Bio, Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Biodexa Pharmaceuticals PLC Unsponsored ADR grew revenue faster over the last twelve months: 60.2% against −49.6%. Valion Bio, Inc. has the higher net margin (0.00% vs −1,155.7%) and the lower return on invested capital (−61.0% vs 0.00%). Across the 14 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 11 and Valion Bio, Inc. on 3.

Valuation

Metric BDRX VBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.14 9.40
P/B n/m 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.20 n/m 0.66
EV/Sales (2.81) 11.09 9.02
Earnings yield (102.95%) (40,026.00%) (32.88%)
Free cash flow yield 0.00% (22,510.36%) (23.13%)

Profitability

Metric BDRX VBIO Biotechnology median
Gross margin 0.00% (58.09%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (489.30%) (51.96%)
Return on assets 0.00% (104.96%) (46.06%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric BDRX VBIO Biotechnology median
Revenue growth (TTM) 60.22% (49.63%) 6.76%
EPS growth (last fiscal year) 89.62% 60.16% 29.88%
Revenue growth, 5-year CAGR (28.78%) 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX VBIO Biotechnology median
Debt to equity 0.00 0.62 0.00
Current ratio 2.41 1.11 4.97
Net debt to EBITDA 1.00 0.79 1.01

Dividend

Metric BDRX VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BDRX VBIO Biotechnology median
Market cap 1.25m 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack